TAKEDA WOULD NOT HAVE THROWN IN MONEY LIKE THAT IF THE INITIAL INVESTIGATIONS WERE NOT POSITIVE!
For suer it appears the initial investigation must have proven to Takeda that the drug has a high chance of being re-instated; otherwise Takeda would not be stupid enough to commit to dollars like they did.
Also stated Takeda taking over all payments even if the reinstatement of the drug and so on. I see this dragging out for awhile, but they talked about the expansion of O and marketing responsibilities. I definitely smell a merger where takeda absorbs AFFY. They and the FDA are highly positive on O why talk about reinstatement and assume all responsibilities if a company was near bankruptcy w/o drug. So my question is why would Takeda step in now in full effort almost to salvage their friend if they didn't have anything to offer.
This is a undeniable concert between the two AFFY/TAKEDA, their playing this one out real good.
Takeda has been around too long to waste a ton of money on a O if it was in dyer's stray. Takeda will make a tender offer after O has been reinstated or coincidentally.
The only issue i have with all of this is that the 180 million + means nothing right now. It says that they will receive 180 mil IF Om returns. IF, I want it to return i do and i think it will, i just want to know how long before AFFY does not have any capital to function. What happens if O returns next year. Will AFFY still be around